Introduction {#s1}
============

Transcription factor IIH (TFIIH) is a 10-subunit protein complex with a total molecular weight of 0.5 MDa that serves a dual role as a general transcription factor for transcription initiation by eukaryotic RNA polymerase II (Pol II), and as a DNA helicase complex in nucleotide excision DNA repair (NER) ([@bib23]; [@bib96]). Mutations in TFIIH subunits that cause the inherited autosomal recessive disorders xeroderma pigmentosum (XP), trichothiodystrophy (TTD), and Cockayne syndrome (CS) are characterized by high incidence of cancer or premature ageing ([@bib18]; [@bib88]). Furthermore, TFIIH is a possible target for anti-cancer compounds ([@bib8]) and therefore of great importance for human health and disease.

The TFIIH core complex is composed of the seven subunits XPB, XPD, p62, p52, p44, p34, and p8, and is the form of TFIIH active in DNA repair ([@bib108]), where TFIIH serves as a DNA damage verification factor ([@bib67]; [@bib72]) and is responsible for opening a repair bubble around damaged nucleotides. This activity depends on both the SF2-family DNA-dependent ATPase XPB, and the DNA helicase activity of XPD ([@bib21]; [@bib32]; [@bib65]). TFIIH function in transcription initiation requires the double-stranded DNA translocase activity of XPB to regulate opening of the transcription bubble ([@bib4]; [@bib37]; [@bib46]), and additionally the CdK activating kinase (CAK) complex, which harbors the kinase activity of CDK7 as well as the Cyclin H and MAT1 subunits ([@bib26]; [@bib38]; [@bib39]; [@bib104]; [@bib108]). Targets of human CDK7 include the C-terminal heptapeptide repeat domain of the largest subunit of Pol II, as well as cell-cycle regulating CDKs ([@bib39]; [@bib104]). MAT1 serves as a bridging subunit that promotes CAK subcomplex formation by interacting with Cyclin H and CDK7 ([@bib26]; [@bib38]), recruits the CAK to the core complex by interactions with XPD and XPB ([@bib1]; [@bib13]; [@bib45]; [@bib93]), and also aids in Pol II-PIC formation by establishing interactions with the core PIC ([@bib48]; [@bib49]; [@bib102]). The presence of MAT1 inhibits the helicase activity of XPD ([@bib1]; [@bib97]), but the mechanism of this inhibition is not fully understood. While the enzymatic activity of XPD is not required for transcription initiation, it is critical for the DNA repair function of TFIIH ([@bib30]; [@bib32]; [@bib65]). Therefore, NER requires the release of the CAK subcomplex from the core complex ([@bib22]). The activities of both XPB and XPD are regulated by interactions with additional TFIIH components, including that of p44 with XPD ([@bib19]; [@bib30]; [@bib60]), and those of the p52-p8 module with XPB ([@bib21]; [@bib20]; [@bib54]; [@bib57]). These interactions are likely to be crucial for TFIIH function, as some are affected by disease mutations ([@bib18]), but they have been only partially characterized mechanistically.

Our previous structure of the TFIIH core-MAT1 complex at 4.4 Å resolution ([@bib45]) allowed modeling of TFIIH in the best-resolved parts of the density map, but several functionally important regions remained unassigned or only partially interpreted because reliable de novo tracing of entire domains in the absence of existing structural models was not possible. Here, we present the complete structure of the human TFIIH core complex in association with the CAK subunit MAT1, determined by phase plate cryo-electron microscopy (cryo-EM) at 3.7 Å resolution. Our structure reveals the complete architecture of the TFIIH core complex and provides detailed insight into the interactions that govern its assembly. Additionally, our cryo-EM maps define the molecular contacts that control the regulation of the XPB and XPD subunits of TFIIH, including the critical p52-XBP interaction, and an extensive regulatory network around XPD, formed by XPB, p62, p44, and MAT1.

Results {#s2}
=======

Structure determination of TFIIH {#s2-1}
--------------------------------

To determine the complete structure of the human TFIIH core complex, we collected several large cryo-EM datasets ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) of TFIIH immuno-purified from HeLa cells using an electron microscope equipped with a Volta phase plate (VPP) ([@bib25]) and a direct electron detector camera mounted behind an energy filter. From a homogeneous subset of approximately 140,000 TFIIH particle images identified by 3D classification ([@bib98]), we reconstructed a 3D cryo-EM density map at 3.7 Å resolution ([Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2A--C](#fig1s2){ref-type="fig"}). This VPP-based cryo-EM map was substantially improved compared to our previous maps obtained without phase plate, both in resolution and interpretability ([Figure 1---figure supplement 2D--G](#fig1s2){ref-type="fig"}), and enabled building, refinement, and full validation of an atomic model of the TFIIH core complex and the MAT1 subunit of the CAK subcomplex ([Figure 1A--C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2B,C](#fig1s2){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}, [3](#supp3){ref-type="supplementary-material"}), while the remainder of the CAK subcomplex is invisible in our map because it is flexibly tethered to the TFIIH core complex. Tracing and sequence register assignment of protein components modeled de novo was facilitated by density maps obtained from focused classification and multibody refinement ([Figure 1---figure supplements 3](#fig1s3){ref-type="fig"}--[5](#fig1s5){ref-type="fig"}) ([@bib6]; [@bib78]), which resulted in density maps of improved interpretability for all three sub-volumes and a slightly improved resolution of 3.6 Å for the XPD-MAT1 region. Both the overall and multibody-refined maps showed clear side chain information ([Figure 1---figure supplement 6A--D](#fig1s6){ref-type="fig"}). Furthermore, our model was corroborated by existing chemical crosslinking-mass spectrometry (CX-MS) data of human TFIIH ([@bib70]) and site-specific crosslinks from yeast TFIIH ([@bib115]) ([Figure 1---figure supplement 6E--I](#fig1s6){ref-type="fig"}, [Supplementary file 4](#supp4){ref-type="supplementary-material"}).

![Structure of the TFIIH core complex.\
(**A, B, C**) Three views of the structure of the TFIIH core complex and MAT1. Subunits are color-coded and labeled (in color); individual domains are labeled (in black) and circled if needed for clarity. (**D**) Domain-level protein-protein interaction network between the components of the TFIIH core complex and MAT1 derived from the interactions observed in our structure. Proteins are shown with the same colors as in A and major unmodeled regions are shown in grey. Abbreviations: CTD: C-terminal domain; DRD: DNA damage recognition domain; FeS: iron sulfur cluster domain; NTD: N-terminal domain; vWFA: von Willebrand Factor A.](elife-44771-fig1){#fig1}

Detailed architecture of TFIIH and structure of p62 {#s2-2}
---------------------------------------------------

Our structure of the TFIIH core complex shows its horseshoe-like overall shape ([Figure 1A--C](#fig1){ref-type="fig"}, [Video 1](#video1){ref-type="video"}), as observed in previous lower-resolution reconstructions of free and PIC-bound TFIIH ([@bib43]; [@bib45]; [@bib49]; [@bib76]; [@bib102]), and allows us to define the complete set of inter-subunit interactions that lead to the formation of the TFIIH core complex directly from our structure ([Figure 1D](#fig1){ref-type="fig"}).

###### Architecture of the TFIIH core complex.

Rotating structure of the TFIIH core complex, followed by views that highlight the interactions of p62 near the nucleotide binding pocket of XPD and near the substrate binding cleft of XPD (binding sites are indicated by a flashing ADP molecule and DNA strand, respectively). Bound substrates, which are not present in our structure, were superposed from PDB ID 6FWS ([@bib16]).

10.7554/eLife.44771.010

The largest subunits of the complex, the SF2-family DNA-dependent ATPases XPB and XPD, both containing two RecA-like domains (RecA1 and RecA2), interact directly ([@bib45]), are on one side of the complex, and are additionally bridged by MAT1 ([Figure 1B](#fig1){ref-type="fig"}), which has been shown to interact with either ATPase in isolation ([@bib13]). On the side facing away from MAT1, XPD interacts with the von Willebrand Factor A (vWFA) domain of p44 ([@bib19]; [@bib30]; [@bib49]; [@bib60]), which in turn forms a tight interaction with p34 via interlocking eZnF domains ([@bib102]) and a p44 RING domain interaction ([@bib87]) ([Figure 1B--D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 6J,K](#fig1s6){ref-type="fig"}), consistent with the formation of a multivalent interaction network between p34 and p44 ([@bib87]). The vWFA domain of p34 recruits p52 by a three-way interaction that involves the most N-terminal winged helix domain in p52 and a helical segment of p62 ([@bib102]) ([Figure 1---figure supplement 6L](#fig1s6){ref-type="fig"}). The p52 C-terminal region comprises two domains; first, the 'clutch' that interacts with XPB ([@bib54]) and second, a dimerization module that binds p8 ([@bib57]), thereby recruiting XPB to TFIIH and cradling XPB RecA2 (see below). In addition to this structural framework that is formed by folded domains, our cryo-EM map reveals several interactions involving extended protein segments, including several interactions formed by p62 ([Figure 2](#fig2){ref-type="fig"}), and an interaction between the p44 N-terminal extension (NTE) and the N-terminal domain (NTD) of XPB ([Figure 1B](#fig1){ref-type="fig"}). To form this interaction, approx. 15 residues of p44 span the distance between the p44 vWFA domain and the XPB NTD, where a small helical motif in p44 contacts XPB residues 72--75, 95--102, and 139--143, in agreement with CX-MS data ([@bib70]) ([Figure 1---figure supplement 6E](#fig1s6){ref-type="fig"}). Partial deletion of the p44 NTE in yeast causes a slow-growth phenotype, suggesting a functional role for this p44-XPB interaction ([@bib115]).

![The structure of p62.\
(**A**) View of the top surface of the TFIIH core complex; p62 is color-coded by structural region. (**B**) The BSD2 (blue) and XPD anchor segments (teal) of p62 (surface) interact with the region around the XPD substrate-binding cavity. (**C**) Residues 346--365 of p62 (yellow) approach the nucleotide-binding pocket of XPD. ADP superposed from the structure of the DinG helicase ([@bib16]). (**D**) Superposition of DNA from the structure of the substrate-bound DinG helicase ([@bib16]) shows that the positions of p62 and RecA1-bound DNA overlap.](elife-44771-fig2){#fig2}

The p62 subunit is almost completely resolved in our structure and exhibits a complex beads-on-a-string-like topology. It fully encircles the top surface of TFIIH ([Figures 1C](#fig1){ref-type="fig"} and [2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), interacting with XPD, p52, p44, and p34, in agreement with previous structural findings ([@bib45]; [@bib102]). Based on these interactions, p62 can be subdivided into three functional regions: (i) the N-terminal PH-domain, disordered in our structure, is responsible for mediating interactions with components of the core transcriptional machinery ([@bib28]; [@bib49]; [@bib102]), transcriptional regulators ([@bib27]), and DNA repair pathways ([@bib42]; [@bib66]; [@bib83]); (ii) residues 108--148 and 454--548 of p62, including the first BSD (BTF2-like, synapse-associated, DOS2-like) domain (BSD1) and the C-terminal 3-helix bundle, play an architectural role by binding to p34 and the extended zinc finger (eZnF) domain of p44 ([Figure 2A](#fig2){ref-type="fig"}, [Figure 1---figure supplement 6J--L](#fig1s6){ref-type="fig"}, [Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}); and (iii) residues 160--365, including the BSD2 domain, are responsible for interactions with and regulation of XPD ([Figure 2B--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1D--F](#fig2s1){ref-type="fig"}).

Specifically, p62 residues 160--365 form three structural elements that interact with XPD ([Figure 2B](#fig2){ref-type="fig"}, [Video 1](#video1){ref-type="video"}), in agreement with previous biochemical, structural, and CX-MS data ([Figure 1---figure supplement 6G](#fig1s6){ref-type="fig"}) ([@bib55]; [@bib70]; [@bib102]). First, an α-helix formed by p62 residues 295--318 binds directly to XPD RecA2 and thereby recruits residues 160--258 of p62, comprising the BSD2 domain and adjacent sequence elements, to this surface of XPD RecA2 ([Figure 2A,B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). Second, p62 residues 266--287 are inserted into the DNA-binding cavity of XPD ([Figure 2B,D](#fig2){ref-type="fig"}), in agreement with previous observations ([@bib102]). This inserted p62 segment directly blocks a DNA-binding site on XPD RecA1 ([Figure 2D](#fig2){ref-type="fig"}) and localizes near the access path to a pore-like structure between the XPD FeS and ARCH domains. While p62 does not directly contact the DNA-binding surface on XPD RecA2, it may still sterically interfere with DNA binding or access to the helicase elements of XPD in this region ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}). Therefore, this segment of p62 may need to move away when XPD binds and unwinds DNA. Third, p62 residues 350--358 form a short α-helix that binds in a cleft between the two RecA-like domains of XPD ([Figure 2C](#fig2){ref-type="fig"}), so that it not only closes the entrance to the nucleotide binding pocket in XPD RecA1 ([Figure 2---figure supplement 1F](#fig2s1){ref-type="fig"}), but also partially overlaps with the predicted location of the nucleotide itself ([Figure 2C](#fig2){ref-type="fig"}), strongly suggesting a role for this p62 sequence element in XPD regulation. The density for these structural elements of p62 (residues 260--300 and 346--365) in our cryo-EM map is weaker than for the remainder of the complex, suggesting a dynamic interaction with XPD that enables them to modulate the access to the nucleotide-binding pocket, the DNA-binding cavity, and the DNA-translocating pore of XPD, depending on the functional state of TFIIH. 3D reconstructions of TFIIH classified for these regions of p62 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) show globally intact TFIIH, both in the presence and absence of the p62 segments at these XPD sites ([Figure 2---figure supplement 1G--J](#fig2s1){ref-type="fig"}), supporting our hypothesis of dynamic regulation, rather than the alternative hypothesis of p62 binding to XPD as a requirement for TFIIH stability ([@bib70]).

Molecular basis of XPB recruitment by p52 {#s2-3}
-----------------------------------------

Our structure of TFIIH resolves the structure and interactions of all four folded domains of human XPB -- two RecA-like domains that form the SF2-family type helicase cassette, a DNA damage recognition domain (DRD)-like domain, and an N-terminal domain (NTD) ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) -- and reveals the molecular basis of XPB recruitment by p52. The XPB NTD encompasses residues 1--165, with the first 55 residues forming an N-terminal extension (NTE), and the remainder assuming a mixed α/β-fold with four α-helices and five β-strands ([Figure 3A](#fig3){ref-type="fig"}). The side chain densities in the cryo-EM map ([Figure 1---figure supplement 6A](#fig1s6){ref-type="fig"}) and CX-MS data ([@bib70]) ([Figure 1---figure supplement 6F](#fig1s6){ref-type="fig"}) both confirm our assignment of this domain. Existing biochemical data show that the XPB NTD is required for integration of XPB into TFIIH ([@bib54]) by forming an interaction with p52 that has been referred to as the 'clutch' ([@bib102]). In our structure, the p52 contribution to the clutch encompasses p52 residues 306--399, which, strikingly, assume the same overall fold as the XPD NTD ([Figure 3B](#fig3){ref-type="fig"}), as hypothesized previously ([@bib49]; [@bib70]), thereby forming a pseudo-symmetric dimer of structurally homologous domains. The two domains interact through their β-sheets, via both hydrophobic and charged interactions ([Figure 3---figure supplement 2A--C](#fig3s2){ref-type="fig"}), and with the most N-terminal β-strand emanating from the XPB NTD extending the p52 β-sheet by additional lateral interactions ([Figure 3A,C](#fig3){ref-type="fig"}).

![Structure and interactions of XPB.\
(**A**) Bottom lobe of TFIIH. XPB RecA1/2 teal, DRD blue, NTD dark blue, p52 yellow, p8 green, p44 NTE red. (**B**) Superposition of the XPB NTD and the p52 clutch domain. (**C**) Mapping of mutations on the XPB NTD and the p52 clutch domain; mutated regions are color-coded or shown as spheres (see text for details). (**D**) The combined interactions of the p52 clutch, the p8-p52 CTD dimer, and the XPB NTD with XPB RecA2 may restrict the conformational flexibility of XPB RecA2 to optimize XPB activity. (**E**) An extension of the DRD (blue) contacts XPD (green). The sequence for which formation of an α-helix is predicted ([@bib58]) is indicated. (**F**) The DRD extension overlaps with the substrate-binding site on XPD RecA2. Substrate DNA modeled from PDB ID 5HW8 ([@bib24]).](elife-44771-fig3){#fig3}

Our structural findings rationalize biochemical data that show that deletion of XPB residues 1--207, but not deletion of residues 1--44, impairs the p52-XPB interaction ([@bib54]) ([Figure 3C](#fig3){ref-type="fig"}). Our structure is also consistent with data indicating that p52 residues 304--381 are critical for the XPB-p52 interaction ([@bib21]; [@bib54]), but does not show any contacts that could explain that reported binding of XPB to p52 residues 1--135 or 1--304 ([@bib54]) ([Figure 3---figure supplement 2D,E](#fig3s2){ref-type="fig"}). The interaction between p52 and XPB not only recruits XPB to TFIIH, but also stimulates its ATPase activity in vitro ([@bib21]). Because our structure does not shown any elements of p52 approaching the XPB nucleotide-binding pocket, we propose that this effect is likely induced by the interactions of p52 with the XPB NTD and RecA2, which may, together with p8 ([@bib20]), properly arrange the XPB helicase cassette to bind and hydrolyze ATP ([Figure 3D](#fig3){ref-type="fig"}) ([@bib46]).

The XPB NTD is the site of the two human disease mutations F99S and T119P, which cause XP and TTD, respectively ([@bib18]). Or structure shows that neither of these residues is in direct contact with p52 or the RecA-like domains of XPB, suggesting that the F99S and T119P mutations exert their detrimental effects through structural perturbation of the XPB NTD ([Figure 3---figure supplements 1B](#fig3s1){ref-type="fig"} and [2F--I](#fig3s2){ref-type="fig"}). Specifically, T119 is located near a turn at the end of a β-strand ([Figure 3---figure supplement 2G](#fig3s2){ref-type="fig"}), where its side chain points towards the solvent. Nevertheless, this residue is highly conserved in eukaryotic XPB from ciliates to humans, in some archaeal and bacterial XPB homologs ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), and in the structurally homologous clutch domain in p52 ([Figure 3---figure supplement 2F--H](#fig3s2){ref-type="fig"}). This conservation suggests that a threonine at this position is important for the efficient folding of this domain in general, and that the T119P mutation may cause its destabilization, resulting in lower levels of active enzyme in TTD patients. Lower overall levels of properly assembled TFIIH have been shown to be a hallmark of TTD ([@bib11]; [@bib30]; [@bib44]) and could explain the disease-causing effect of T119P in vivo even though recombinant TFIIH carrying this mutation retains some activity in both transcription initiation and NER ([@bib21]). A less likely alternative, given the conservation of the equivalent residue in the p52 clutch, is that T119 is involved in an interaction with a factor that is critical for cellular function, for example in NER.

The F99S mutation affects a residue that is conserved throughout eukaryotic XPB ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), is inserted into a conserved hydrophobic pocket, and localizes to an α-helix at the XPB contact site with the p44 N-terminal extension ([Figure 3---figure supplement 2I](#fig3s2){ref-type="fig"}). This mutation is likely to impair the stability and folding of the XPB NTD. Unlike T119P, this mutation leads to impaired DNA opening in NER assays, reduced interaction with p52, reduced ATPase activity ([@bib21]), and strong impairment in DNA damage repair ([@bib89]), suggesting a severe effect on the structure of the XPB NTD.

Natural and synthetic mutations in the *Drosophila melanogaster* homolog of p52 that lead to disease-like phenotypes in flies and have similar defects when introduced into human cells ([@bib40]) map directly to the p52-XPB interface, explaining their detrimental phenotypes ([Figure 3C](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}).

Our structure assigns XPB residues 165--300 to a DRD-like domain that connects the NTD to the RecA-like domain ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), the deletion of which is lethal in yeast ([@bib115]). The DRD is a DNA-binding domain found in DNA repair enzymes and chromatin remodelers ([@bib71]; [@bib81]) and has been implicated in DNA damage recognition in archaeal XPB ([@bib35]; [@bib94]). Our 3.7 Å-resolution map of TFIIH reveals that in eukaryotic XPB, one β-strand of the DRD of archaeal XPB is replaced by an insertion of approximately 70 residues that exhibits relatively low sequence conservation ([Figure 3E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) and shifts the domain boundaries of the human XPB DRD-like domain with respect to previous sequence alignments ([@bib35]; [@bib82]). The part of this insertion resolved in our map consists of a negatively charged linker and an α-helical element that contacts XPD directly ([Figure 3E,F](#fig3){ref-type="fig"}). The surface on XPD involved in this interaction has been implicated in the initial step of DNA substrate binding by XPD ([@bib24]; [@bib64]). Density features and secondary structure prediction indicate the presence of several aromatic side chains of XPB near the interface ([Figure 3E](#fig3){ref-type="fig"}), where they might form contacts resembling those of nucleoside bases of XPD-bound DNA substrates ([Figure 3F](#fig3){ref-type="fig"}). Thus, XPB may modulate substrate binding by XPD, further reinforcing the idea that XPD activity is regulated by several other components of TFIIH.

Conformational dynamics of the TFIIH core complex {#s2-4}
-------------------------------------------------

In order to investigate the dynamics of TFIIH, we analyzed the conformational landscape of the particles in our cryo-EM dataset ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}; see Materials and methods for details) ([@bib78]). This analysis revealed the relative motions of the two ATPases and their domains ([Figure 4A](#fig4){ref-type="fig"}). The major mode of motion, which involves the breaking of the interaction between XPB and XPD, resembles the conformational transition of TFIIH when it enters the Pol II-PIC and binds to DNA ([@bib45]; [@bib49]; [@bib102]) ([Figure 4---figure supplement 2A--C](#fig4s2){ref-type="fig"}, [Video 2](#video2){ref-type="video"}). Analysis of our TFIIH structure and comparison with that of the complex within the Pol II-PIC maps ([@bib49]; [@bib102]) allowed us to identify a specific rearrangement at the interface between the clutch and adjacent winged helix domain in p52 ([Figure 4B](#fig4){ref-type="fig"}) as the basis of this conformational change. A structural unit composed of XPB, p8 and the clutch domain of p52 undergoes a downward motion upon DNA-binding within the Pol II-PIC ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2B,C](#fig4s2){ref-type="fig"}). This conformational change in TFIIH upon PIC entry also appears to break the interaction between MAT1 and the XPB DRD-like domain ([Figure 4C](#fig4){ref-type="fig"}), which in turn might serve to enable positioning of the CDK7-cyclin H dimer within the CAK subcomplex at the appropriate location for Pol II-CTD phosphorylation in the mediator-bound Pol II-PIC ([Figure 4D](#fig4){ref-type="fig"}) ([@bib91]; [@bib102]). Our structural comparison also reveals that a TFIIE-XPB interaction that has been implicated in XPB regulation ([@bib102]) may depend on the existence of the open conformation of TFIIH, as there would be steric hindrance in a complex involving the closed conformation of TFIIH ([Figure 4---figure supplement 2D--F](#fig4s2){ref-type="fig"}).

![Conformational dynamics of TFIIH.\
(**A**) Results of multibody analysis (also see [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and Materials and methods for details). Several major modes of motion (Cα displacement indicated by colored arrows; distances \< 2.5 Å are not shown) involve the enzymatic subunits of the TFIIH core complex or their domains. (**B**) Motion of the p52 clutch domain (closed conformation gold, open conformation light yellow) and associated XPB NTD (closed conformation blue, open conformation light blue) relative to the remainder of p52 (brown), based on comparison of free and PIC-bound TFIIH structures and fitting of domains into Pol II-PIC cryo-EM maps ([@bib49]; [@bib102]). (**C**) XPB motions from the closed conformation (free TFIIH; darker blue hues) and the open conformation (TFIIH-PIC; lighter hues). The MAT1-XPB contact probably dissociates during this rearrangement. (**D**) Schematic model for the conformational transitions in MAT1 and repositioning of the CAK kinase module during Pol II-PIC entry of TFIIH.](elife-44771-fig4){#fig4}

###### Conformational rearrangements of TFIIH during incorporation into the Pol II-PIC.

Transition of TFIIH from the closed conformation observed in our structure of free TFIIH to the open conformation present in Pol II-PIC bound TFIIH, followed by a depiction of TFIIH in the context of the Pol II-PIC. Coordinates (PDB 5IYB, PDB 5OQJ) and maps (EMD-8131, EMD-8132, EMD-3846) used for core-Pol II-PIC depictions and analysis of TFIIH conformation from ([@bib49]; [@bib102]).

10.7554/eLife.44771.019

Structure of XPD {#s2-5}
----------------

The structure of XPD shows the conserved domain arrangement of two RecA-like domains (RecA1 and RecA2), with the FeS and ARCH domain insertions in RecA1 ([@bib24]; [@bib36]; [@bib64]). The quality of the map allowed us to interpret the density for the N- and C-termini of XPD, which closely approach each other near the nucleotide-binding site within RecA1 ([Figure 5A](#fig5){ref-type="fig"}). The N-terminus of XPD forms a short two-stranded β-sheet near the nucleotide-binding site in XPD RecA1 (which is empty in our structure) and may contribute to the stabilization of the bound nucleotide via the aromatic side chains of Y14 and Y18, the latter being affected by the Y18H mutation in an XP/TTD patient ([@bib62]) ([Figure 5---figure supplement 1A--C](#fig5s1){ref-type="fig"}). The XPD C-terminal segment runs along the side of XPD RecA2 and interacts with the linker between RecA1 and RecA2 ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). The C-terminal segment includes the site of the K751Q polymorphism ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), and deletion of this terminal segment causes XP in human patients ([@bib18]).

![Structure and regulation of XPD.\
(**A**) Structure of XPD colored by domain. N- and C-terminal segments (blue and purple, respectively) of XPD are indicated. An ADP molecule superposed from the structure of DinG ([@bib16]) denotes the nucleotide-binding pocket in XPD RecA1, which is empty in our structure. (**B**) Structure of the FeS domain. Residues critical for XPD enzymatic activity (blue) and damage verification (teal) are indicated. The R112H mutation causes TTD in human patients. ARCH domain insertion brown. DNA superposed from ([@bib16]). The region corresponding to the view in this panel (but viewed from the back side) is indicated in (**A**). (**C**) Interaction network of XPD with surrounding TFIIH subunits (interacting regions colored, remainder grey). (**D**) Cartoon model for repression and de-repression of XPD by MAT1, XPB, and p62. (**E**) XPD-p44 interacting regions (defined as residues within \<4 Å of the neighboring protein) are colored in dark green (XPD) and dark red (p44). Residues discussed in the text are shown as sticks; those with mutation data (natural variants or experimental constructs) are colored yellow on XPD, teal on p44. The remainder of the β4-α5 loop harboring the synthetic p44 mutations is colored teal as well.](elife-44771-fig5){#fig5}

Before XPD-bound DNA reaches the helicase motifs in the RecA like domains, it passes through a pore-like structure next to the 4FeS cluster at the interface between the FeS and ARCH domains ([Figure 5---figure supplement 1E,F](#fig5s1){ref-type="fig"}) ([@bib16]; [@bib24]; [@bib64]; [@bib69]; [@bib118]). This region was poorly defined in previous TFIIH reconstructions, but our cryo-EM map now shows side-chain densities for the aromatic residues Y158, F161, and F193, which are critical for the DNA-binding, ATPase, and helicase activities of XPD ([@bib65]), as well as for residues Y192 and R196, which form part of a DNA lesion recognition pocket ([@bib72]) ([Figure 5B](#fig5){ref-type="fig"}). This functionally important region is only partially conserved in archaeal XPD homologs ([Figure 5---figure supplement 1G--I](#fig5s1){ref-type="fig"}) ([@bib36]; [@bib64]; [@bib118]). A eukaryotic-specific loop insertion in the XPD ARCH domain ([@bib45]; [@bib102]) closely approaches this binding pocket ([Figure 5B](#fig5){ref-type="fig"}) and may serve to regulate the binding of DNA in the lesion recognition pocket such as to prevent untimely access of substrates to the XPD pore.

Interactions and regulation of XPD {#s2-6}
----------------------------------

Our structure of TFIIH shows that XPD forms architectural and regulatory interactions with four other TFIIH subunits: XPB, p62, p44, and MAT1, which together form a cradle-like structure around XPD ([Figure 5C](#fig5){ref-type="fig"}). We described above two interactions that could potentially regulate XPD activity: the newly defined interaction of an insertion element in the XPB DRD with a DNA-binding site in XPD ([Figure 3E,F](#fig3){ref-type="fig"}); and XPD-p62 interactions involving the XPD nucleotide binding pocked and DNA binding cavity ([Figure 2](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1D--F](#fig2s1){ref-type="fig"}) that implicate p62, as well as XPB, in XPD regulation. Additionally, it is known that the helicase activity of XPD is inhibited by the CAK subcomplex ([@bib5]; [@bib97]). The contacts we see between MAT1 and XPD localize to the ARCH domain of XPD and the N-terminal RING domain and helical bundle of MAT1 (residues 1--130) ([Figure 5C](#fig5){ref-type="fig"}), in agreement with previous structural ([@bib45]; [@bib102]) and biochemical analysis ([@bib1]; [@bib70]; [@bib115]). The interaction between the XPD ARCH domain and the MAT1 helical bundle is characterized by charge complementarity ([Figure 5---figure supplement 1J--M](#fig5s1){ref-type="fig"}). This interface is highly dynamic, enabling the release of MAT1 and the entire CAK subcomplex from TFIIH during NER, as well as its subsequent re-association to regenerate a transcription-competent TFIIH ([@bib22]).

Insertion of substrate DNA into the pore between the XPD ARCH and FeS domains requires the flexibility of the XPD ARCH domain ([@bib24]), and large domain motions have been observed in the structure of the DNA-bound homologous helicase DinG upon nucleotide binding ([@bib16]). This suggests a role for the mobility of the ARCH domain in both DNA loading and DNA translocation by the XPD helicase. Our structure suggests that binding of the MAT1 helical bundle and RING domain to the ARCH domain may prevent such motion and therefore the subsequent substrate loading and XPD helicase activity ([Figure 5D](#fig5){ref-type="fig"}), in agreement with biochemical data that show XPD inhibition upon MAT1 binding ([@bib97]), as well as reduced single-stranded DNA affinity of TFIIH in the presence of the CAK ([@bib67]). Conversely, release of MAT1 from XPD might allow the ARCH domain to move more freely, thereby de-repressing XPD. Furthermore, displacement of the MAT1 α-helix that connects XPD to XPB may allow XPB to move away from XPD, thereby unmasking the substrate-binding site on XPD RecA2 that is otherwise occluded by the DRD insertion element ([Figure 5D](#fig5){ref-type="fig"}). This latter conformational change would be similar, overall, to that seen for TFIIH upon incorporation into the Pol II-PIC, where XPD and XPB move apart and density for the MAT1 helix is missing ([Figure 4C](#fig4){ref-type="fig"}) ([@bib49]; [@bib102]). We propose that the combined unmasking of the XPD substrate binding site and the enhanced flexibility of the XPD ARCH domain may both contribute to de-repression of the XPD helicase upon release of MAT1. This mechanism of XPD inhibition by MAT1 does not exclude the possibility of additional repression of NER activity by the CAK subcomplex through phosphorylation of NER pathway components ([@bib5]).

Our structure also resolves in detail the XPD-p44 interaction, a known regulatory interface ([@bib30]; [@bib60]; [@bib65]) affected by numerous disease mutations ([@bib18]; [@bib45]; [@bib65]) ([Figure 5E](#fig5){ref-type="fig"}). The relatively small interaction surface between p44 and XPD, of just 940 Å^2^ ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}), contrasts with the much larger buried surface of 3300 Å^2^ between XPD and p62, or 1580 Å^2^ for the p52-XPB interaction. This smaller interaction surface may result in higher sensitivity to mutations that localize at the XPD-p44 interface. Our structure, thus, rationalizes the deleterious effect of a number of natural and synthetic mutations in this interface (see Appendix 1 and [Figure 5---figure supplement 2B--E](#fig5s2){ref-type="fig"}), including mutations L174W and T175R in the β4-α5 loop of p44 ([Figure 5E](#fig5){ref-type="fig"}) ([@bib60]; [@bib103]), which may lead to steric clashes in the densely packed interface ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}), and the XPD R722W mutation ([@bib65]), which disrupts the salt bridge with D75 in p44 and may additionally cause steric clashes with neighboring p44 residues due to the bulky tryptophan side chain ([Figure 5---figure supplement 2C](#fig5s2){ref-type="fig"}). Our structure also shows that, in contrast to a previously proposed model ([@bib70]), the XPD R616P, D673G, and G675R disease mutations act either via disruption of the XPD structure or the XPD-p44 interface, but not via disruption of the interaction with p62 (see Appendix 1 and [Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}). Notably, the p44-dependet stimulation of XPD activity does not depend on the presence of p62 ([@bib30]; [@bib60]; [@bib65]). We were also able to map a number of disease mutations onto our XPD structure ([Figure 6A](#fig6){ref-type="fig"}, [Video 3](#video3){ref-type="video"}, Appendix 2) and analyze in detail the interactions involving the affected residues (example shown in [Figure 6B](#fig6){ref-type="fig"}). Our analysis confirms that XP mutations mostly localize near the helicase substrate-binding or active sites, while TTD mutations predominantly localize to the periphery of XPD ([Figure 6](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) ([@bib36]; [@bib69]), where they disrupt TFIIH assembly and cause the transcription defects that are a hallmark of this disease ([@bib30]) (Appendix 2).

![Disease mutations in XPD.\
(**A**) Residues affected by disease mutations are shown as spheres (XP purple; TTD yellow; CS-XP orange). Conserved helicase elements for DNA binding are shown in blue, for nucleotide binding and hydrolysis in green, and for coupling of nucleotide hydrolysis and DNA translocation in brown. DNA superposed from ([@bib16]). (**B**) Salt bridge between R658 (RecA2) and D240 (RecA1) visualized in our structure that is affected by the temperature sensitive TTD mutation R658C ([@bib113]).](elife-44771-fig6){#fig6}

###### Visualization of disease mutations mapped onto the structure of the TFIIH core complex.

The human disease mutations discussed in the manuscript are shown in the context of the TFIIH structure. The areas depicted are: (i) The interaction interface between p8 and XPB, affected by a TTD mutation; (ii) the XPB N-terminal domain, affected by XP and TTD mutations; (iii) the active site region of XPD, affected mostly by XP and XP/CS mutations; (iv) the DNA-binding cleft of XPD, affected mostly by XP mutations; (v) the interaction site between XPD and p44, affected mostly by TTD mutations; (vi) the interaction site between MAT1 and XPD, affected by a TTD mutation (see text for further details).

10.7554/eLife.44771.025

Discussion {#s3}
==========

Our study reveals the complete structure of the TFIIH core complex and provides mechanistic insights into the regulation of its two component helicases. Specifically, it shows XPD wrapped by numerous interactions with XPB, p62, p44, and MAT1 ([Figure 5C,D](#fig5){ref-type="fig"}), indicating how its activity can be tightly controlled and de-repressed only when its enzymatic function is needed. XPD activity is not needed and most likely inhibited during transcription initiation, but it may also be tightly controlled during NER, when repair bubble opening and lesion verification need to be coordinated with the recruitment and activation of the damage recognition and processing machinery ([Figure 7](#fig7){ref-type="fig"}). While the regulation of XPD by MAT1 and p44 has been studied in some detail, and the domain motions in TFIIH suggest a straightforward mechanism for liberating the substrate-binding site on XPD RecA2, less was known about the interplay between XPD and p62. Our structure now shows how p62 is able to impede both substrate and nucleotide binding in XPD RecA1, and hints at dynamic structural changes of p62 during de-repression and enzymatic activity of XPD, possibly regulated by other components of the transcription or NER pathways.

![Implications for assembly of the repair bubble during NER.\
(**A**) Schematic of DNA-bound TFIIH (DNA damage verification pocket in XPD and DNA 5'-phosphates indicated by purple and orange spheres, respectively) Binding of both XPB and XPD to the damaged strand would lead to extrusion of a bubble when XPD scans in the 5'−3' direction, while XPB may be stationary or contribute to bubble extrusion if translocating in the 3'−5' direction (DNA superposed from PDB IDs 6FWR, 5OQJ ([@bib16]; [@bib102])). (**B**) Binding of XPB to the undamaged strand would enable the entire complex to scan in 5'−3' direction, given the opposing polarities of the two ATPases/helicases involved. (**C**) Model for the assembled repair bubble. Positions of NER factors are approximate. XPG-p62 PH domain interaction according to ([@bib42]). See Discussion for details.](elife-44771-fig7){#fig7}

Our results allow us to put extensive biochemical data on the NER pathway into a structural context ([Figure 7](#fig7){ref-type="fig"}). Depending on whether XPB binds to the damaged ([Figure 7A](#fig7){ref-type="fig"}) or undamaged ([Figure 7B](#fig7){ref-type="fig"}) strand, the combined action of XPD and XPB could lead to the extrusion of a DNA bubble ([Figure 7A](#fig7){ref-type="fig"}) or to the tracking of the entire complex towards the lesion ([Figure 7B](#fig7){ref-type="fig"}), which is initially located 3' of the TFIIH binding site ([@bib106]). The latter hypothesis is attractive in the context of biochemical data that show that XPD tracks along the damaged strand in the 5' to 3' direction until it encounters the DNA lesion in order to verify the presence of a bona fide NER substrate ([@bib12]; [@bib67]; [@bib72]; [@bib77]; [@bib106]; [@bib117]). It is worth noting that the length of DNA fragments excised during NER is approx. 29 nt, with 22 nt located 5' and 5 nt located 3' of a thymine dimer lesion ([@bib53]). According to our structure, the 22 nt 5'-fragment corresponds well to the estimated 20 nt of DNA that are required to span the distance from the DNA damage verification pocket in XPD ([@bib72]) to the helicase elements of XPB. This proposal is compatible with a model in which TFIIH sitting on the open repair bubble might track towards the lesion, where it would stop due to inhibition of XPD ([@bib67]; [@bib72]; [@bib77]), at which point double incision could be initiated. However, this model ([Figure 7B](#fig7){ref-type="fig"}) would require strong DNA bending before both XPB and XPD could be loaded. Additionally, it has not been fully resolved whether XPB participates in DNA translocation or unwinding during TFIIH activity in NER ([@bib67]), which would be required in the tracking model ([@bib67]), or whether it exclusively acts to anchor the complex in the vicinity of the DNA lesion ([@bib21]; [@bib82]).

Independently of the orientation of the repair bubble, our structural data are compatible with literature data introduced above and a model ([Figure 7C](#fig7){ref-type="fig"}) that localizes XPG near XPD and p62 (site of 3'-incision), XPF-ERCC1 near XPB (site of 5'-incision), and with RPA binding the non-damaged strand ([@bib33]). We have currently not included XPA in this model because its interactions with distinct partners or participation in various processes, such as involvement in CAK release ([@bib22]), binding to p8 ([@bib121]), and participation in helicase stalling after lesion recognition ([@bib67]), suggest its localization to various, often distant sites on TFIIH, or the repair bubble in general ([@bib107]).

In summary, our structure of the human TFIIH core complex reveals the interactions that govern the architecture and function of this molecular machine, provides new insights into the regulation of its enzymatic subunits, and thus constitutes an excellent framework for further mechanistic studies of TFIIH in the context of larger DNA repair and transcription assemblies.

Materials and methods {#s4}
=====================

TFIIH purification, cryo-EM specimen preparation, and data collection {#s4-1}
---------------------------------------------------------------------

TFIIH was purified and cryo-EM grids were prepared on carbon-coated C-flat CF 4/2 holey carbon grids (Protochips) using a Thermo Fisher Scientific Vitrobot Mk. IV, as previously described ([@bib45]). To improve on our previous 4.4 Å cryo-EM map of human TFIIH ([@bib45]), which was based on four cryo-EM datasets (3 of which were retained in the 4.4 Å reconstruction, datasets 8--10 in [Supplementary file 1](#supp1){ref-type="supplementary-material"}) from a low-base Titan microscope (Thermo Fisher Scientific) equipped with a side-entry holder (Gatan) and a K2 Summit direct electron detector (Gatan), we collected new data (dataset seven in [Supplementary file 1](#supp1){ref-type="supplementary-material"}) on a Titan KRIOS microscope (Thermo Fisher Scientific) operated at 300 kV extraction voltage and equipped with a C~S~-corrector, a K2 Summit direct electron detector (Gatan) operated in super-resolution counting mode, and a Quantum energy filter (Gatan). This dataset was collected under the same imaging conditions as our previous data (i.e. 37,879 x magnification resulting in 1.32 Å pixel size, and at a total exposure of 40 e^-^ Å^−2^), except for the change of microscope. Datasets 7--10 could be combined to yield a cryo-EM map at 4.3 Å resolution (not shown), however, this did not lead to a substantial improvement in map quality, suggesting that particle alignment quality was limiting. We therefore opted to collect further data on a Titan KRIOS electron microscope (Thermo Fisher Scientific) operated at 300 kV acceleration voltage and equipped with a Volta Phase Plate (VPP), a Gatan Quantum energy filter (operated at 20 eV slit width), and a Gatan K2 Summit direct electron detector (operated in super-resolution counting mode). VPP data (datasets 1--6 in [Supplementary file 1](#supp1){ref-type="supplementary-material"}) were collected according to the defocus acquisition technique ([@bib25]; [@bib59]) at 43,478 x magnification, resulting in a physical pixel size of 1.15 Å on the object scale, with a total electron exposure of 50 e^-^ Å^−2^ at an exposure rate of 6.1 e^-^ Å^−2^ s^−1^ during an exposure time of 8.25 s, dose fractionated into 33 movie frames (50 frames for dataset 6). Data collection was monitored on-the-fly using FOCUS ([@bib10]) to ensure proper evolution of the VPP-induced phase shift.

Cryo-EM data processing {#s4-2}
-----------------------

Initially, we used data collected in 10 microscopy sessions, six sessions using the VPP and four sessions without the VPP, resulting in \>30'000 total micrographs, of which approx. 16,000 were retained after inspection of the quality of Thon rings and CTF fitting (for details, see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Movie stacks were aligned and dose weighed using MOTIONCOR2 ([@bib120]). The aligned, dose weighed sums from the datasets collected at 1.32 Å pixel size (datasets 7--10) were up-sampled to 1.15 Å per pixel to match the scale of the micrographs collected using the VPP (datasets 1--6) after calibrating the two magnifications to each other based on 3D reconstructions computed from the two types of data. CTF parameters were estimated using GCTF ([@bib119]) and particles were picked using GAUTOMATCH (Kai Zhang, MRC Laboratory of Molecular Biology, Cambridge UK) or RELION ([@bib100]) using templates generated from a preliminary run without reference templates. All subsequent data processing was performed in RELION 2 ([@bib61]; [@bib99]) or RELION 3 ([@bib78]; [@bib122]).

To remove false positive particle picks and broken particles, an initial 3D classification at low resolution (7.5° angular sampling) was performed on each dataset individually (datasets 3, 4, 5), or on a few pooled datasets if appropriate (datasets 1 and 2 were pooled as they used the same batch of specimen; the non-VPP datasets 7--10 were joined because only few micrographs were retained due to more stringent quality criteria compared to our previous study; and dataset six was initially classified together with particles from dataset four to compensate for particle orientation bias in dataset 6, see [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In summary, a total of \>2,000,000 initial particle picks were subjected to this initial low-resolution 3D classification, identifying approx. 820,000 intact particles that were subjected to further processing. After 3D auto-refinement and another round of 3D classification, performed separately for the VPP and non-VPP data because the two data types were spuriously separated into distinct classes in combined RELION 3D classification runs, the best classes (one from VPP and non-VPP data each) resulting from the high-resolution 3D classifications were refined according to the gold-standard refinement procedure (fully independent half-sets), resulting in a 3.9 Å-resolution reconstruction according to the FSC = 0.143 criterion ([@bib92]; [@bib101]). Beam tilt refinement in RELION 3 ([@bib122]) improved the map computed from the final subset of VPP data (138,659 particle images) to 3.7 Å resolution. The non-VPP data no longer improved the reconstruction after beam tilt correction and was therefore discarded at this point. The final map was post-processed by application of a B-factor of −142 A^2^ and low-pass filtration to the nominal 3.7 Å resolution for visualization and later coordinate refinement.

We note that even though the final reconstruction comprises only a relatively small fraction of the total particle picks, the first 3D refinement from 786,755 VPP particle images ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) resulted in a 4.3 Å-resolution map that is in excellent agreement with the final map, except for lower resolution and worse map quality caused by residual heterogeneity that was addressed in the subsequent 3D classification step to yield the final set of 138,659 particle images. Therefore, we conclude that our final reconstruction is representative of the overall particle population in the dataset.

To facilitate the interpretation of less ordered or only partially occupied parts of the structure, including the p62 BSD2 domain, the MAT1 RING domain, the MAT1 three-helix bundle at the XPD arch domain, and the N-terminus of XPD, we used signal subtracted classification ([@bib6]; [@bib79]) (p62 BSD2 domain, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), focused classification (MAT1 RING domain, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}), and multibody refinement ([@bib78]) (MAT1 three-helix bundle and XPD N-terminus, [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). For these classification procedures, we used only the VPP data because 3D classification separated VPP and conventional cryo-EM data into distinct classes, rendering combined classification ineffective. Multibody refinement led to only a slight improvement in resolution for the XPD-MAT1 body (to 3.6 Å) relative to the overall refined best map, and only during the first two iterations, likely due to the relatively small size of the individual bodies and the resulting limited signal for alignment. However, the above-mentioned structural elements showed improved density features ([Figure 1---figure supplement 5B](#fig1s5){ref-type="fig"}) and could be more reliably interpreted in the multibody-refined XPD-MAT1 map (green in [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}; also used in [Figure 1---figure supplement 2E,F](#fig1s2){ref-type="fig"}). Overall, the use of VPP data in this work resulted in substantial improvements both in nominal resolution ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}) and map quality ([Figure 1---figure supplement 2E--G](#fig1s2){ref-type="fig"}) compared to our previous 4.4 Å-resolution structure.

Model building and refinement {#s4-3}
-----------------------------

The previous structure of the human TFIIH core complex ([@bib45]) and of yeast TFIIH in the Pol II-PIC ([@bib102]) were docked into the cryo-EM map and used as the basis for atomic modeling in O ([@bib56]) and COOT ([@bib31]). In addition to these models, the structure of the human p34 VWFA-p44 RING domain complex ([@bib87]), the N-terminal RING domain of MAT1 ([@bib41]), the C-terminal RecA-like domain of human XPB ([@bib52]) and several homology models for the p52 winged-helix domains generated using the PHYRE2 web server ([@bib58]) based on templates PDB IDs 3F6O and 1STZ ([@bib68]) were used for model building.

### Building of 52 {#s4-3-1}

The structure of p52 was traced and built completely de novo, with the exception of the winged-helix domains and the very C-terminal domain, where a homology model was placed into the cryo-EM map together with the p8 structure ([@bib57]; [@bib114]) and adjusted to the density.

### XPB {#s4-3-2}

The structure of the XPB NTD was also built de novo, the structure of the DRD was extensively re-built, and the RecA-like domains were rebuilt to improve the fit to the density.

### XPD {#s4-3-3}

The improved cryo-EM map enabled detailed re-building of XPD, including correction of register shifts in the more poorly ordered regions of the protein and extension of the N- and C-termini.

### MAT1 {#s4-3-4}

The N-terminal MAT1 RING domain ([@bib41]) was first docked into the focused classified density and combined with the rest of the TFIIH model, were it helped guide the assignment of the sequence register to the MAT1 model, in combination with density features of large side chains in the helical regions.

### Building of p34 {#s4-3-5}

The human p34 structure ([@bib87]) was docked into the map as is, extended near the interaction site with p52, and combined with a completely re-built model of the C-terminal eZnF domain ([@bib102]).

### Building of p44 {#s4-3-6}

The p44 VWFA fold needed only minor rebuilding and was combined with the eZnF domain and the C-terminal human RING domain model ([@bib87]; [@bib102]). The p44 NTE was built according to the density at the contact site with XPB and guided by CX-MS data ([@bib70]). Both the features of the cryo-EM map and crosslinks of the p44 NTE to p34, p52, and XPB ([Figure 1---figure supplement 6E](#fig1s6){ref-type="fig"}) unambiguously confirm the tracing of this segment towards the XPB NTD, rather than alternative tracing towards XPD (this density is now assigned to p62, in agreement with p62-XPD crosslinks; see below and [Figure 1---figure supplement 6G](#fig1s6){ref-type="fig"}).

### Building of p62 {#s4-3-7}

The p62 protein was modeled based on the placement of the BSD domains (PDB ID 2DII), secondary structure prediction, extension of docked coordinates ([@bib45]; [@bib102]), and new tracing of the protein chain. Placement of the regions near XPD, where density is weak overall, was guided by matching the succession of secondary structure elements along the p62 sequence with helical densities in the cryo-EM map ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), and corroborated by CX-MS data ([@bib70]), which showed excellent agreement of p62-XPD crosslinking data with the structure ([Figure 1---figure supplement 6G](#fig1s6){ref-type="fig"}). Crosslinks between p62 and p44 showed a relatively large proportion of outliers ([Supplementary file 4](#supp4){ref-type="supplementary-material"}), which may be due to the fact that the sequence register of the p62 segments to which these crosslinks map is not well constrained. These segments were modeled as poly-alanines and deposited without sequence assignment (UNK; [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Maps low-pass filtered to 6 Å and sharpened by a B-factor of only −100 Å^2^ were used to guide docking of domains and assess the continuity of the density in poorly ordered regions of the protein ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}).

The resulting coordinate model ([Supplementary file 2](#supp2){ref-type="supplementary-material"}) was refined against the final overall reconstruction at 3.7 Å resolution using the real space refinement program in PHENIX ([@bib2]; [@bib3]) and validated using the MTRIAGE program in PHENIX and the MOLPROBITY web server ([@bib15]). Ramachandran, C~β~, rotamer, and secondary structure restraints were used throughout the refinement to ensure good model geometry at the given resolution. Data used in the refinement excluded spatial frequencies beyond the nominal 3.7 Å resolution of the cryo-EM map to prevent over-fitting. Additionally, by specifically monitoring the bond length and bond angle r.m.s.d. values, the real space refinement program in PHENIX automatically estimates the relative weighing of the restraint and map data to maintain good model geometry and to prevent over-refinement of the structure ([@bib2]; [@bib3]). Because the automatically determined weight fluctuated between approximately 3 and 6 during a typical refinement run, we used the average value of 4.5 for the final refinement (five macro cycles of global optimization and B-factor refinement). The N-terminal RING domain of MAT1 and the BSD1 domain of p62, for which only poorly resolved density is present in the final cryo-EM map, were additionally restrained by reference restraints ([@bib50]) using the NMR structures of the corresponding domains (PDB ID 1G25 and 2DII, respectively) ([@bib41]). The side chains of these two domains (with the exception of residues involved in zinc finger formation and of prolines) were truncated at the Cβ position to reflect the lower resolution of the corresponding densities. The FSC curve between the refined coordinate model and the cryo-EM map extends to 3.9 Å and the distribution of B-factors in the refined coordinate model ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}) mirror the local resolution of the cryo-EM map ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}), as expected. Refinement statistics are given in [Supplementary file 3](#supp3){ref-type="supplementary-material"} and are typical for structures in this resolution range (100^th^ percentile for MOLPROBITY clash score and overall score ([@bib15])).

Flexibility analysis {#s4-4}
--------------------

For the analysis of conformational dynamics of TFIIH, VPP datasets 1 and 2 were subjected to multibody refinement in RELION 3 ([@bib78]) using six masks ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). After completion of multi-body refinement, we used RELION three to run a principal component analysis to identify the principal modes of motion of the bodies relative to each other ([@bib78]). The volume series for the first 12 principal components were reconstructed and difference densities (green and purple in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) were computed between the most extreme states in each series and are shown in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. Subsequently, roughly 20,000 particles corresponding to both ends of the distribution were used for selected principal components and subjected to 3D refinement, resulting in maps of approx. 10 Å resolution. It is important to note that the particles used for these refinements, and the subsequent analysis shown in [Figure 4A](#fig4){ref-type="fig"}, were un-subtracted original particle images containing the entire TFIIH. These refinements are therefore not directly affected by any limitations on alignment accuracy that would arise from alignment of smaller sub-volumes of TFIIH. We also repeated this analysis for two different data subsets (the final 138,659 particle-subset that gave rise to the 3.7 Å-resolution reconstruction and the complete set of 786,755 VPP particles resulting from the initial 3D classification) using only three bodies for multibody refinement (providing more signal for alignment per body) and obtained consistent results overall, with the exception that the ranking of the principal components changed in some instances.

The refined atomic model of the TFIIH core complex, subdivided into suitable rigid bodies, was then rigid-body refined into these volumes using PHENIX real space refinement ([@bib3]) and coordinate displacement between the two resulting models for each principal component was plotted to obtain an initial assessment of the modes of motion present in the TFIIH dataset ([Figure 4A](#fig4){ref-type="fig"}). For actual structural interpretation ([Figure 4B,C](#fig4){ref-type="fig"}), the final cryo-EM maps of the TFIIH core complex (this work) and TFIIH in the context of the Pol II-PIC ([@bib102]) were used.

Other {#s4-5}
-----

Figures were created using PyMol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC.) and the UCSF Chimera package from the Computer Graphics Laboratory, University of California, San Francisco (supported by NIH P41 RR-01081) ([@bib85]). Protein-protein interface statistics were determined using PISA ([@bib63]). Multiple sequence alignments were performed with Clustal Omega ([@bib105]).

Data availability {#s4-6}
-----------------

The cryo-EM map of the human TFIIH core complex at 3.7 Å and the refined coordinate model have been deposited to the EMDB and PDB with accession codes EMD-0452 and PDB-6NMI, respectively. Additional cryo-EM maps resulting from the classification of the dataset for presence of the MAT1 RING domain and for the p62 BSD2 domain (both presence and absence) have been deposited to the EMDB with accession codes EMD-0587, EMD-0589, and EMD-0588, respectively. The multibody-refined maps for XPD-MAT1, XPB-p8-p52 (clutch, CTD), and p44-p34-p62-p52 (N-terminal region) have been deposited with accession codes EMD-0602, EMD-0603, and EMD-0604, respectively.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences R01-GM63072 to Eva Nogales.

-   http://dx.doi.org/10.13039/100000011Howard Hughes Medical Institute to Eva Nogales.

-   http://dx.doi.org/10.13039/501100001711Swiss National Science Foundation Advanced PostDoc Mobility Fellowship P300PA_160983 to Basil J Greber.

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences R35-GM127018 to Eva Nogales.

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences P01-GM063210 to Eva Nogales.

-   http://dx.doi.org/10.13039/501100001711Swiss National Science Foundation Advanced PostDoc Mobility Fellowship P300PA_174355 to Basil J Greber.

We thank D Wigley for sharing of structural data, S Scheres for sharing computer code before publication, R Tjian, S Zheng, and D King for supplying XPB mAB and peptides for TFIIH purification, P Grob for microscopy support, A Chintangal and P Tobias for computing support, and Z Yu and C Hong for data collection at the Janelia Research Campus cryo-EM facility. We acknowledge the use of the resources of the National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science user facility supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This work was funded through NIGMS grants R01-GM63072, P01-GM063210, and R35-GM127018 to EN. BJG was supported by fellowships from the Swiss National Science Foundation (projects P300PA_160983, P300PA_174355). EN is a Howard Hughes medical investigator.

Additional information {#s5}
======================

No competing interests declared.

Investigation, Writing---original draft, Performed cryo-EM specimen preparation, data processing, atomic model building, and coordinate refinement, Contributed to data collection.

Investigation, Contributed to data collection.

Resources, Investigation, Performed HeLa cell culture and purified TFIIH.

Supervision, Funding acquisition, Writing---review and editing, Directed the study.

Additional files {#s6}
================

10.7554/eLife.44771.027

###### Data collection statistics.

All datasets were acquired on Gatan K2 Summit direct electron detectors mounted in 300 kV-electron microscopes with three-condenser type electron optics. The high rejection rate for the data collected without VPP was due to poorer CTF resolution estimates compared to the VPP data, likely because of the use of a low-base Titan with a less stable side entry holder for most of these data. Abbreviations: TEM, transmission electron microscope; VPP, volta phase plate; Σ, sum.
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###### Components of the TFIIH structure.
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###### Data collection, map and model refinement, model validation.
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###### Result summary of mapping of CX-MS data ([@bib70]) onto the TFIIH structure.
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Data availability {#s7}
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The cryo-EM map of the human TFIIH core complex at 3.7 Å and the refined coordinate model have been deposited to the EMDB and PDB with accession codes EMD-0452 and PDB-6NMI, respectively. Additional cryo-EM maps resulting from the classification of the dataset for presence of the MAT1 RING domain and for the p62 BSD2 domain (both presence and absence) have been deposited to the EMDB with accession codes EMD-0587, EMD-0589, and EMD-0588, respectively. The multibody-refined maps for XPD-MAT1, XPB-p8-p52 (clutch, CTD), and p44-p34-p62-p52 (N-terminal region) have been deposited with accession codes EMD-0602, EMD-0603, and EMD-0604, respectively.

The following datasets were generated:

GreberBJTosoDBFangJNogalesE2019Cryo-EM map of the human TFIIH core complex at 3.7 ÅElectron Microscopy Data BankEMD-0452

GreberBJTosoDBFangJNogalesE2019Refined coordinate model of the human TFIIH core complex at 3.7 ÅProtein Data Bank6NMI

GreberBJTosoDBFangJNogalesE2019Cryo-EM map resulting from the classification of the dataset for presence of the MAT1 RING domainElectron Microscopy Data BankEMD-0587

GreberBJTosoDBFangJNogalesE2019Cryo-EM map resulting from the classification of the dataset for presence of the p62 BSD2 domainElectron Microscopy Data BankEMD-0589

GreberBJTosoDBFangJNogalesE2019Cryo-EM map resulting from the classification of the dataset for absence of the p62 BSD2 domainElectron Microscopy Data BankEMD-0588

GreberBJTosoDBFangJNogalesE2019Multibody-refined map for XPD-MAT1Electron Microscopy Data BankEMD-0602

GreberBJTosoDBFangJNogalesE2019Multibody-refined map for XPB-p8-p52 (clutch, CTD)Electron Microscopy Data BankEMD-0603

GreberBJ2019Multibody-refined map for p44-p34-p62-p52 (N-terminal region)Electron Microscopy Data BankEMD-0604

10.7554/eLife.44771.033

The XPD-p44 interface {#s8}
=====================

XPD serves a dual role within TFIIH: Its helicase activity is essential for TFIIH function in NER ([@bib65]; [@bib116]), and it serves as an architectural element in transcription, enabling the proper placement of the CAK subcomplex within the Pol II PIC ([@bib1]; [@bib29]; [@bib30]; [@bib45]; [@bib47]; [@bib49]; [@bib76]; [@bib91]; [@bib93]; [@bib102]; [@bib110]; [@bib112]). The XPD-p44 interaction is critical both for the enzymatic and architectural roles of XPD ([@bib19]; [@bib30]; [@bib60]; [@bib65]). Therefore, disruption of the XPD-p44 interface can simultaneously cause NER defects and impair transcription initiation, which leads to a TTD phenotype in human patients ([@bib30]). Our structure provides a detailed view of this interaction interface, which encompasses the p44 loops β1-α1, β4-α5, β5-α6, and β6-α7 connecting β-strands and α-helices in the p44 VWA domain ([Figure 5E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Mutations L174W, T175R, and D178A in the p44 β4-α5 loop have been shown to abrogate the p44-XPD interaction and to reduce the helicase activity of XPD, implicating this region in XPD activation ([@bib60]; [@bib103]). Our structure suggests that the insertion of large residues (L174W, T175R) into the tightly packed p44-XPD interface ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}) is likely to lead to steric clashes, while the D178A mutation would break a likely salt bridge with XPD R592 ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}). Strikingly, the R592P mutation in XPD, the side chain of which packs against the p44 β4-α5 loop in wild type XPD, causes TTD in human patients ([@bib18]), underscoring the importance of this interaction.

In XPD, RecA2 loop residues 531--533, 563--565, 589--592, 612--616, and the helical segment 718--725 form the p44 interaction interface ([Figure 5E](#fig5){ref-type="fig"}). Using recombinant human and *Chaetomium thermophilum* proteins, it has been shown that the XPD R722W mutation impairs the interaction between p44 and XPD, thereby interfering with both the p44-dependent stimulation of the XPD ATPase and helicase activities in NER, and architectural role of p44 in transcription initiation ([@bib65]). Our structure shows that the R722W mutation disrupts a salt bridge to p44 D75, and the bulky tryptophan side chain may additionally cause steric clashes with neighboring p44 residues, explaining the deleterious effect of the mutation ([Figure 5E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2C](#fig5s2){ref-type="fig"}). It has been proposed that the R616P, D673G, and G675R disease mutations, which impair the p44-XPD interaction and the XPD helicase activity ([@bib30]), exert their deleterious effect by impairing the interaction between XPD and p62 ([@bib70]). However, our structure shows that G675 is buried in the core of XPD ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}), where accommodation of the large arginine side chain in G675R will disrupt the structure of the protein. XPD D673 is located in a β-strand in the vicinity of the XPD-p62 interface ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}); however, no direct interactions of this residue with p62 are observed. XPD R616 is located at the p44-XPD interface, where its side chain is packed against neighboring residues (e.g. Y674, located between the D673 and G675, the sites of the D673G and G675R mutations). R616 or Y674 may engage in interactions with p44 E204 ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}). These interactions would be disrupted in the R616P mutant. Altogether, these observations suggest that these mutations act either via disruption of the XPD structure or the XPD-p44 interface, not via p62. Nevertheless, a contribution of p62 to the stabilization of the p44-XPD interface cannot be excluded because several p62 elements are observed near the interface ([Figure 5---figure supplement 2E](#fig5s2){ref-type="fig"}). As discussed in the main text, some of these interactions are dynamic ([Figure 4---figure supplement 2G--J](#fig4s2){ref-type="fig"}) and unlikely to be strictly required for the stability of the p44-XPD interface.

10.7554/eLife.44771.034

Mapping of XPD mutations {#s9}
========================

In addition to our analysis of the XPD-p44 interface and the mutations located in its vicinity, we were also able to map numerous other human disease mutations onto our structure ([Figure 6](#fig6){ref-type="fig"}). Our results are in good agreement with the hypotheses derived from comparative modeling based on homologous bacterial DNA repair enzymes ([@bib9]), archaeal XPD homologs ([@bib36]; [@bib69]; [@bib118]), and our previous lower-resolution TFIIH structure ([@bib45]). Several XP mutations map in the regions that interact with bound DNA ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), as confirmed by superposing homologous DNA-bound helicase structures ([@bib16]), or in the conserved motifs near the ATPase active site ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). These mutations impair XPD helicase activity ([@bib30]; [@bib36]; [@bib69]), causing the NER defects that manifest in the XP disease symptoms. As explained above, TTD mutations tend to map to the periphery of XPD, including the XPD-p44 interface ([Figure 5E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, [Figure 6---figure supplement 1C,D](#fig6s1){ref-type="fig"}), the ARCH domain ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}), or the FeS domain ([Figures 5B](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). The C259Y mutation in the ARCH domain likely impairs the proper folding of this domain due to steric hindrance introduced by the large tyrosine side chain, which in turn impairs association of the CAK subcomplex through disruption of MAT1 association, as discussed previously ([@bib45]; [@bib69]; [@bib118]). Consistent with its observed location in our structure ([Figure 5B](#fig5){ref-type="fig"}), the R112H mutation in the FeS domain leads to destabilization of the 4FeS cluster ([@bib95]), which in turn leads to the disruption of folding of this entire domain ([@bib36]) and lower TFIIH levels overall ([@bib11]). Another TTD mutation that does not localize to the periphery of XPD is the particularly interesting temperature-sensitive mutation R658C, for which patients show exacerbated symptoms, including complete hair loss, when they develop a fever ([@bib113]). This residue is located at the interface between the XPD RecA1 and RecA2 domains, where it forms a salt bridge across the domain interface ([Figure 6B](#fig6){ref-type="fig"}). This interface would be partially destabilized by the mutation at normal temperature and more severely disrupted at elevated temperature, leading to stronger disease symptoms.

We also mapped onto our structure the location of the so-called *rem* mutations in Rad3, the yeast homolog of XPD. These mutations increase the affinity of Rad3 for DNA, which leads to retention of Rad3/XPD on DNA lesions, incomplete NER reactions, and subsequent DNA breakage upon arrival of a DNA replication fork ([@bib51]; [@bib75]). We mapped the *rem* mutations Rad3-E236G (XPD E235), Rad3-A237T (XPD A236), and Rad3-H661Y (XPD H659), as well as the human XP-CS mutation XPD-G675R, which also exhibits elevated DNA affinity but reduced helicase activity in an archaeal model system ([@bib36]) and DNA breakage in patient cells ([@bib109]), onto our structure ([Figure 6---figure supplement 1F](#fig6s1){ref-type="fig"}). XPD E235 and A236 are part of the conserved helicase motif II (signature sequence DEAH, [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}, [Figure 6---figure supplement 1F](#fig6s1){ref-type="fig"}) ([@bib34]), and as such critical for nucleotide hydrolysis. Notably, the neighboring XPD D234, also part of motif II ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}, [Figure 6---figure supplement 1B,F](#fig6s1){ref-type="fig"}), is a human XP mutation ([@bib18]). XPD H659 is located nearby, and contacts R601, which locates to the immediate vicinity of the DNA based on superposition with structures of DNA-bound helicases ([@bib14]; [@bib16]) ([Figure 6---figure supplement 1F](#fig6s1){ref-type="fig"}) and is affected by an XP mutation ([@bib18]). In agreement with previous proposals, the *rem* mutations are therefore localized near regions responsible for ATP hydrolysis and DNA binding, consistent with the idea that they lead to stalling of NER complexes at DNA lesions, which may ultimately lead to incomplete NER, DNA breaks, failure to re-start transcription, and the XP-CS phenotype ([@bib74]).

In summary, our structure pinpoints the locations of XPD mutations that provide insight into human disease mechanisms, and in most cases resolves the density for the side chains of the affected residues, thereby providing a structural framework for the detailed analysis of the interactions of the affected residues and the effects of these mutations.

10.7554/eLife.44771.051
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The complete structure of the human TFIIH core complex\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Nikolaus Grigorieff as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Cynthia Wolberger as the Senior Editor. The following individuals involved in review of your submission have also agreed to reveal their identity: Seth A Darst (Reviewer \#2); James M Berger (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is a comprehensive study of the core structure of TFIIH, a transcription factor that acts also as a DNA repair enzyme. The authors present an atomic model, built into a cryo-EM map, that contains eight out of the ten core complex subunits, some incomplete due to partial disorder in the subunits. This new structure explains numerous biochemical and functional data found in the literature, including details of TFIIH assembly and regulation of the DNA repair activity. The authors resolve several critical interactions that knit the complex together and they are able to map human disease mutations onto the assembly to rationalize their molecular effects. This study will be a key contribution to both the eukaryotic transcription and DNA repair fields.

Minor points:

1\) What is meant by \"extreme\" motion?

2\) Subsection "Structure determination of TFIIH": Please provide the full range of resolutions, not just the best value.

3\) What is meant by \"initial 3D classification\"?

4\) Data collection: Please include a figure showing a typical micrograph and a set of 2D class averages.

5\) Data analysis: The authors mention a problem of preferred orientation. Please show a figure plotting orientations.

6\) Figure 4 and Figure 4---figure supplement 1: The visualization of the flexibility results is difficult to follow. In Figure 4, would it be possible to magnify the structures in panel A and perhaps eliminate the light and dark blue dots in areas that do not move much? In the supplement, it might be better to limit the display of the densities to two colors, or maybe consider showing 2D sections instead to highlight the flexible domains. Enlarging the figure may also help.

7\) Overall, it would be helpful to have videos that clarify numerous aspects of the structural findings, such as subunit organization (Figure 1), domain motions (Figure 4), and the positions of various disease-linked mutations.

8\) Figure 1D. Please indicate what the lines mean between subunits; presumably crosslinks?

9\) Close-ups: In a number of figures, close-ups are shown next to overviews of a subunit or the complex (for example, Figure 5A and B, Figure 6A and B, but also elsewhere). It would help if there is some indication in the overviews of where the close-ups are located.

10\) Multi-body refinement: The authors state that this did not improve the resolution of the map much and led to only a modest (albeit important) improvement of map features, and that this might indicate increased resolution-limiting alignment errors of the domains included in each body. Since the flexibility analysis presented in Figure 4 and Figure 4---figure supplement 1 relies on these alignment, how reliable is this analysis? Looking at the domain movements indicated in Figure 4, it looks as if some of them represent rotations around the domain centers. Could this be merely an artifact of data processing from rotational blurring as implemented by the maximum likelihood approach? The authors should discuss this and, if appropriate, reevaluate these results.

11\) Atomic model refinement: Which map was the model refined against? Was it one of the half maps or the full map? The authors should discuss how they limited over-refinement.

12\) About 50% of the videos were discarded. This number seems high. The authors indicate that some images did not show CTF fringes to high resolution, and that their data selection was quite stringent. However, a 3.6-Å reconstruction does not impose much of a limit on the data quality. What was the reason for so many bad images, and what were the quantitative criteria for inclusion/rejection?

13\) Of the 2 million particles picked initially, only 7% ended up in the final reconstruction. How do the authors know that these are the \"correct\" 7%? Could they have missed a major conformation that would have told a very different story?

10.7554/eLife.44771.052

Author response

> Summary:
>
> This is a comprehensive study of the core structure of TFIIH, a transcription factor that acts also as a DNA repair enzyme. The authors present an atomic model, built into a cryo-EM map, that contains eight out of the ten core complex subunits, some incomplete due to partial disorder in the subunits. This new structure explains numerous biochemical and functional data found in the literature, including details of TFIIH assembly and regulation of the DNA repair activity. The authors resolve several critical interactions that knit the complex together and they are able to map human disease mutations onto the assembly to rationalize their molecular effects. This study will be a key contribution to both the eukaryotic transcription and DNA repair fields.

We thank the reviewers and editors for the positive assessment of our manuscript. We will address the detailed comments in point-by-point answers below. Other than the changes required for addressing these questions and comments, we have made the following changes and improvements to the manuscript:

i\) We previously deposited the main cryo-EM map and coordinate model at the EMDB and PDB. We have now deposited six additional cryo-EM maps to the EMDB: The maps classified for the p62 BSD2 domain (EMD-0588, EMD-0589), the density classified for the *MAT1* RING domain (EMD-0587), and the multibody-refined best-quality maps (EMD-0602, EMD-0603, EMD-0604). The accession codes are provided in the appropriate location in the manuscript (section "Data availability" at the end of the manuscript).

ii\) Supplementary files 2 and 3 were updated with the accession codes of the map and model deposited at the EMDB and PDB as well as with the final refinement statistics of the model (Supplementary file 3) and the list of residues deposited as UNK (Supplementary file 2). The statistics are slightly improved overall, e.g. the Ramachandran outliers are down to 0.2% from 0.3% and the bond angle RMSD is down to 1.08° from 1.19°.

iii\) Figure 1---figure supplement 2: Panel B was updated with a model vs. map FSC curve computed against a cryo-EM map filtered at 3.5 Å resolution. The lack of a hard cut-off at 3.7 Å resolution results in a more natural decay of the model vs. map curve at high resolutions (because the coordinates correlate with the map beyond the nominal map resolution in the core of the structure), while the resolution estimates are unchanged (both of these observations are as expected). Panel C was updated with the B-factors of the final coordinate model deposited at the PDB.

iv\) Figure 1---figure supplement 5: While the manuscript was under review, it was brought to our attention that post-processing unfiltered half maps from intermediate steps of multibody refinement runs can lead to artifacts in the FSC curves at very high resolution (close to Nyquist frequency) and is discouraged. Even though to the best of our knowledge, these issues did not affect our reconstructions in any way, we opted to completely avoid any risk of artifacts. We therefore replaced the initially used multibody-refined maps with maps resulting from a regular final refinement cycle in RELION 3 (using data out to Nyquist frequency), which led to the same improvements in map interpretability observed before, but slightly different resolution estimates (3.6-3.8 Å depending on the sub-volume; see also the point-to-point answer on that topic below). These have been updated in the figure (along with the FSC curves).

v\) Figure 4C and D now use more accurate representations of the "open" conformation of TFIIH, based on fitting of component domains of our human TFIIH structure into the cryo-EM maps of the human and yeast Pol II-PIC. The legend has been adjusted accordingly; the information content of the figures is otherwise unchanged and no changes to the text were needed.

> Minor points:
>
> 1\) What is meant by \"extreme\" motion?

We reworded this:

"... because it is flexibly tethered to the TFIIH core complex".

> 2\) Subsection "Structure determination of TFIIH": Please provide the full range of resolutions, not just the best value.

While the manuscript was under review, we modified the way the multi-body refinement was conducted (see general comments above). The XPD-*MAT1* body is now resolved at 3.6 Å resolution, while the remaining two bodies did not see an improvement in resolution (even though the map quality increased in certain regions in all bodies). This has been clarified in the manuscript:

"..., which resulted in density maps of improved interpretability for all three sub-volumes and a slightly improved resolution of 3.6 Å for the XPD-MAT1 region."

> 3\) What is meant by \"initial 3D classification\"?

We refer to the initial 3D classification to remove broken particles and false-positive particle picks, as introduced in the preceding sentence. We have clarified this by specifying the angular sampling used, and mentioning that this classification was a coarse angular sampling, low-resolution classification:

"To remove false positive particle picks and broken particles, an initial 3D classification at low resolution (7.5° angular sampling) was performed on each dataset individually (datasets 3, 4, 5) \[...\]). In summary, a total of \> 2,000,000 initial particle picks were subjected to this initial low-resolution 3D classification, identifying approx. 820,000 intact particles that were subjected to further processing."

> 4\) Data collection: Please include a figure showing a typical micrograph and a set of 2D class averages.

These panels have been added to Figure 1---figure supplement 1A and B.

> 5\) Data analysis: The authors mention a problem of preferred orientation. Please show a figure plotting orientations.

We have added a representation of the orientation distribution to Figure 1---figure supplement 1D. The orientations populate mostly a zone that corresponds to particles adhering to the carbon support with the long axis of the complex parallel to the support layer, and a range of orientations arising from rotation of the particles around that long axis. Dataset 6 showed stronger orientation bias compared to the other datasets. Therefore, we pooled these particles with a different dataset for initial 3D classification to avoid bias in classification at this step. Subsequently, the resulting particles from dataset 6 were joined with the remaining datasets.

The legend to the new figure panel reads:

"(D) Depiction of the orientation distribution of the particle images in the final reconstruction. As also evident from the 2D classes (C), the orientations populate mostly a zone that corresponds to particles adhering to the carbon support with long axis of the complex parallel to the support layer, and a range of orientations arising from rotation of the particles around that long axis."

> 6\) Figure 4 and Figure 4---figure supplement 1: The visualization of the flexibility results is difficult to follow. In Figure 4, would it be possible to magnify the structures in panel A and perhaps eliminate the light and dark blue dots in areas that do not move much?

We have modified this figure according to the suggestion. We have removed all of the vectors shorter than 2.5 Å and rearranged the panels such that the figure can appear larger in the typeset version of the article.

> In the supplement, it might be better to limit the display of the densities to two colors, or maybe consider showing 2D sections instead to highlight the flexible domains. Enlarging the figure may also help.

We have visually simplified the figure by using the same color for the two volumes corresponding to the ends of the eigenvector movie and additionally, we enlarged the panels by removing 4 panels representing eigenvectors that are not used or discussed further in the manuscript.

> 7\) Overall, it would be helpful to have videos that clarify numerous aspects of the structural findings, such as subunit organization (Figure 1), domain motions (Figure 4), and the positions of various disease-linked mutations.

We have added three videos on the overall architecture of the complex (Video 1), conformational changes during incorporation into the transcription pre-initiation complex (Video 2), and mapping of disease mutations (Video 3). We hope that these videos will help both reviewers and readers visualize the spatial arrangement of the structural elements discussed in the paper.

> 8\) Figure 1D. Please indicate what the lines mean between subunits; presumably crosslinks?

The lines do not indicate crosslinks, but actual protein-protein interactions derived from the structure, mapped at the domain level. Elucidating which domains of which TFIIH subunits interact with each other has been the goal of a number of previous publications in the field, and this figure panel provides the answer to this question. We have emphasized this point in the figure legend:

> \"Domain-level protein-protein interaction network between the components of the TFIIH core complex and MAT1 derived from the interactions observed in our structure.\"
>
> 9\) Close-ups: In a number of figures, close-ups are shown next to overviews of a subunit or the complex (for example, Figure 5A and B, Figure 6A and B, but also elsewhere). It would help if there is some indication in the overviews of where the close-ups are located.

We have added this information to the figures mentioned (Figure 5A, 6A).

> 10\) Multi-body refinement: The authors state that this did not improve the resolution of the map much and led to only a modest (albeit important) improvement of map features, and that this might indicate increased resolution-limiting alignment errors of the domains included in each body.

Decreasing alignment power with decreasing molecular weight (and decreasing total available signal) of the complex under study is a problem that is commonly encountered in single particle cryo-EM structure determination, and is one of the reasons for why phase plates such as the VPP have been developed (e.g. Khoshouei et al., 2017, as cited in the manuscript).

> Since the flexibility analysis presented in Figure 4 and Figure 4---figure supplement 1 relies on these alignment, how reliable is this analysis? Looking at the domain movements indicated in Figure 4, it looks as if some of them represent rotations around the domain centers. Could this be merely an artifact of data processing from rotational blurring as implemented by the maximum likelihood approach? The authors should discuss this and, if appropriate, reevaluate these results.

The reviewers bring up an important point. However, we believe that our approach should eliminate the risk of generating this type of artifact. It is important to note that after multi-body refinement (alignment of sub-volumes) and principal component analysis, we selected the complete, non-subtracted particle images (showing entire TFIIH complexes) corresponding to the tails of the distribution (i.e. largest conformational difference) and re-refined these small datasets. Coordinates were then rigid body refined into these volumes, and the positional differences of these fitted coordinates is what is plotted in Figure 4A. Therefore, importantly, the analysis and conclusions shown in Figure 4 do not directly rely on the alignment of the sub-volumes. The alignment of sub-volumes only gave the principal components according to which the particle images for re-refinement were selected. If this selection had been based merely on alignment errors of the sub-volumes without any actual conformational differences occurring in the actual particle images, we would not expect to find these same conformational differences in the volumes obtained from refinement of complete particle images. We clarified and elaborated on this point in the Materials and methods section:

\"It is important to note that the particles used for these refinements, and the subsequent analysis shown in Figure 4A, were un-subtracted original particle images containing the entire TFIIH. \[...\] We also repeated this analysis for two different data subsets (the final 138,659 particle-subset that gave rise to the 3.7 Å-resolution reconstruction and the complete set of 786,755 VPP particles resulting from the initial 3D classification) using only 3 bodies for multibody refinement (providing more signal for alignment per body) and obtained consistent results overall, with the exception that the ranking of the principal components changed in some instances.\"

> 11\) Atomic model refinement: Which map was the model refined against? Was it one of the half maps or the full map? The authors should discuss how they limited over-refinement.

The model was refined against the full map to utilize the full signal available in the cryo-EM dataset. We estimate that we would lose approximately 0.3-0.5 Å resolution if we were to use only a half-map for refinement.

The real space refinement algorithm in PHENIX automatically estimates the relative weighing of geometry restraints and density (Adams et al., 2010; Afonine et al., 2018; as cited in the manuscript) based on the bond length and bond angle RMSD values to prevent overfitting. Because these automated target weights fluctuated between refinement cycles, sometimes giving rise to arbitrarily higher or lower weights in the last iteration (which determines the final fit to map and geometry quality), we used a weight of 4.5 for the final 5 macro-cycles of refinement, corresponding to the average of weights estimated by PHENIX during a trial run on the same data. These settings resulted in bond length and bond angle RMSD values in the expected range (1.08° for bond angles, 0.01 Å for bond lengths). We have added this information in the Materials and methods section of the manuscript:

\"Additionally, by specifically monitoring the bond length and bond angle r.m.s.d values, the real space refinement program in PHENIX automatically estimates the relative weighing of the restraint and map data to maintain good model geometry and to prevent over-refinement of the structure (Adams et al., 2010; Afonine et al., 2018). Because the automatically determined weight fluctuated between approximately 3 and 6 during a typical refinement run, we used the average value of 4.5 for the final refinement (5 macro cycles of global optimization and B-factor refinement).\"

As detailed in the manuscript, we additionally used reference restraints, where available, to avoid overfitting of coordinates in poorly resolved regions of the cryo-EM map.

> 12\) About 50% of the videos were discarded. This number seems high. The authors indicate that some images did not show CTF fringes to high resolution, and that their data selection was quite stringent. However, a 3.6-Å reconstruction does not impose much of a limit on the data quality. What was the reason for so many bad images, and what were the quantitative criteria for inclusion/rejection?

As detailed in Supplementary file 1, the high rejection rate affected mostly the non-VPP data, which was affected by higher variability than the VPP data. Most of the non-VPP data was collected on a low-base FEI Titan (non-KRIOS) microscope with a side-entry holder, where stage drift is a concern, and consequently, more images were rejected due to poor resolution of the CTF fitting (worse than 4.5 Å). Unexpectedly, the data from the Janelia Research Campus Titan KRIOS was affected by similar problems, with large numbers of micrographs exhibiting CTF fit resolutions of only 5 Å. Inclusion of these lower-quality micrographs and combining them with the VPP data degraded the resolution of the reconstructions at an early stage, so stringent selection criteria were applied to the non-VPP data and inclusion of the resulting data improved the reconstruction until the VPP data alone exceeded 3.9 Å resolution, at which point even the best non-VPP data no longer improved the resolution and was consequently removed from the calculations (as described in the manuscript).

We have added a short note to the legend of Supplementary file 1:

\"The high rejection rate for the data collected without VPP was due to poorer CTF resolution estimates compared to the VPP data, likely because of the use of a low-base Titan with a less stable side entry holder for most of these data.\"

> 13\) Of the 2 million particles picked initially, only 7% ended up in the final reconstruction. How do the authors know that these are the \"correct\" 7%? Could they have missed a major conformation that would have told a very different story?

We are confident that we did not miss a major conformation of TFIIH that would have led to a vastly different interpretation. The 2 million initial particle picks included false positives (e.g. non-particles showing only carbon, or ice contamination) as well as presumably damaged complexes that never resulted in a reconstruction with discernable features. Notably, almost 40% of the initial particles (approx. 800,000 particle images) were retained after the first round of 3D classification and their refinement resulted in a reconstruction that is highly similar to the final reconstruction, albeit at lower resolution (approx. 4.3 Å) and considerably worse map quality because of TFIIH flexibility (mostly motion of XPB that results in opening and closing of the TFIIH "horseshoe"). We have clarified this in the Materials and methods section:

"We note that even though the final reconstruction comprises only a relatively small fraction of the total particle picks, the first 3D refinement from 786,755 VPP particle images (Figure 1---figure supplement 1) resulted in a 4.3 Å-resolution map that is in excellent agreement with the final map, except for lower resolution and worse map quality caused by residual heterogeneity that was addressed in the subsequent 3D classification step to yield the final set of 138,659 particle images. Therefore, we conclude that our final reconstruction is representative of the overall particle population in the dataset."

[^1]: **Competing interests:** The authors declare that no competing interests exist.
